Literature DB >> 16231320

Sterol profiling of amniotic fluid: a routine method for the detection of distal cholesterol synthesis deficit.

F Chevy1, L Humbert, C Wolf.   

Abstract

OBJECTIVES: Smith Lemli Opitz syndrome (SLOS) caused by a deficit of 3beta-hydroxysterol-Delta7 reductase was the first sterol deficit described with multiple malformations. The lack of specificity of many morphological abnormalities detected by ultrasound and their frequency have justified routine screening of amniotic fluid (AF) for sterols by GC-MS. The examination contributes to an improved knowledge of the sterol status in the fluid.
METHODS: A series of sterol profiles is collated here. Accumulation of 7- and 8-dehydrocholesterol are diagnostic for SLOS. However, a number of other sterols have also been detected by GC-MS in control AF and their presence may be confusing. RESULTS AND
CONCLUSIONS: In addition to cholesterol, the level of which varies as function of the gestational age, lathosterol is present together with trace amounts of 7- and 8-dehydrocholesterol and other precursors such as desmosterol, lanosterol, and dimethylsterol. Phytosterols are also present in 70% of AF samples that have been tested. Besides SLOS, GC-MS examination of amniotic fluid can detect various sterol deficits associated with malformations (lathosterolosis, desmosterolosis, X-linked chondrodysplasia, and particular Antley-Bixler syndrome). Practical conclusions support GC-MS as a routine method to investigate skeletal and central nervous system malformations. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16231320     DOI: 10.1002/pd.1254

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  7 in total

Review 1.  Genetic alterations affecting cholesterol metabolism and human fertility.

Authors:  Anthony M DeAngelis; Meaghan Roy-O'Reilly; Annabelle Rodriguez
Journal:  Biol Reprod       Date:  2014-08-13       Impact factor: 4.285

2.  New splicing pathogenic variant in EBP causing extreme familial variability of Conradi-Hünermann-Happle Syndrome.

Authors:  Mathilde Pacault; Marie Vincent; Thomas Besnard; Caroline Kannengiesser; Claire Bénéteau; Sébastien Barbarot; Xénia Latypova; Khaldia Belabbas; Antonin Lamazière; Norbert Winer; Madeleine Joubert; Stéphane Bézieau; Bertrand Isidor; Sandra Mercier; Mathilde Nizon; Stéphanie Leclerc-Mercier; Smail Hadj-Rabia; Fabienne Dufernez
Journal:  Eur J Hum Genet       Date:  2018-08-22       Impact factor: 4.246

3.  Comparison of the liquid-ordered bilayer phases containing cholesterol or 7-dehydrocholesterol in modeling Smith-Lemli-Opitz syndrome.

Authors:  Galya Staneva; Claude Chachaty; Claude Wolf; Peter J Quinn
Journal:  J Lipid Res       Date:  2010-02-10       Impact factor: 5.922

4.  Potential of sterol analysis by liquid chromatography-tandem mass spectrometry for the prenatal diagnosis of Smith-Lemli-Opitz syndrome.

Authors:  William J Griffiths; Yuqin Wang; Kersti Karu; Emmanuel Samuel; Shane McDonnell; Martin Hornshaw; Cedric Shackleton
Journal:  Clin Chem       Date:  2008-06-12       Impact factor: 8.327

5.  CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.

Authors:  Lydie Boussicault; Sandro Alves; Antonin Lamazière; Anabelle Planques; Nicolas Heck; Lara Moumné; Gaëtan Despres; Susanne Bolte; Amélie Hu; Christiane Pagès; Laurie Galvan; Francoise Piguet; Patrick Aubourg; Nathalie Cartier; Jocelyne Caboche; Sandrine Betuing
Journal:  Brain       Date:  2016-01-29       Impact factor: 13.501

6.  Profiling of ob/ob mice skeletal muscle exosome-like vesicles demonstrates combined action of miRNAs, proteins and lipids to modulate lipid homeostasis in recipient cells.

Authors:  Audrey Jalabert; Laura Reininger; Emmanuelle Berger; Yohann Coute; Emmanuelle Meugnier; Alexis Forterre; Elizabeth Errazuriz-Cerda; Alain Geloen; Myriam Aouadi; Karim Bouzakri; Jennifer Rieusset; Sophie Rome
Journal:  Sci Rep       Date:  2021-11-03       Impact factor: 4.379

7.  Dendrogenin A drives LXR to trigger lethal autophagy in cancers.

Authors:  Gregory Segala; Marion David; Philippe de Medina; Mathias C Poirot; Nizar Serhan; François Vergez; Aurelie Mougel; Estelle Saland; Kevin Carayon; Julie Leignadier; Nicolas Caron; Maud Voisin; Julia Cherier; Laetitia Ligat; Frederic Lopez; Emmanuel Noguer; Arnaud Rives; Bruno Payré; Talal Al Saati; Antonin Lamaziere; Gaëtan Despres; Jean-Marc Lobaccaro; Silvere Baron; Cecile Demur; Fabienne de Toni; Clément Larrue; Helena Boutzen; Fabienne Thomas; Jean-Emmanuel Sarry; Marie Tosolini; Didier Picard; Michel Record; Christian Récher; Marc Poirot; Sandrine Silvente-Poirot
Journal:  Nat Commun       Date:  2017-12-04       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.